Lindbrook Capital’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.34K | Buy |
191
+28
| +17% | +$929 | ﹤0.01% | 1858 |
|
|
2024
Q4 | $5.61K | Sell |
163
-8
| -5% | -$275 | ﹤0.01% | 1931 |
|
|
2024
Q3 | $6.84K | Sell |
171
-9
| -5% | -$360 | ﹤0.01% | 1872 |
|
|
2024
Q2 | $5.43K | Buy |
180
+48
| +36% | +$1.45K | ﹤0.01% | 1956 |
|
|
2024
Q1 | $4.43K | Hold |
132
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q4 | $4.26K | Buy |
+132
| New | +$4.26K | ﹤0.01% | 1968 |
|
|
2023
Q3 | – | Sell |
-11
| Closed | -$387 | – | 2761 |
|
|
2023
Q2 | $387 | Buy |
+11
| New | +$387 | ﹤0.01% | 2558 |
|
|
2023
Q1 | – | Sell |
-76
| Closed | -$4.19K | – | 2845 |
|
|
2022
Q4 | $4.19K | Sell |
76
-61
| -45% | -$3.36K | ﹤0.01% | 1911 |
|
|
2022
Q3 | $6K | Buy |
137
+132
| +2,640% | +$5.78K | ﹤0.01% | 1559 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2609 |
|